Drugs / APD515
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01331746 | Sep 2011 → Dec 2012 | — | Acacia Pharma Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APD515 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01331746 ↗ |
| Route | Other | “20 mg oromucosal-oral administration qds for 7 days” NCT01331746 ↗ |